UK markets open in 3 hours 30 minutes

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
12.34-0.05 (-0.40%)
At close: 04:00PM EDT
12.34 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-503,144
-541,489
-532,784
-457,892
606,073
Depreciation & amortisation
1,406
1,393
1,122
4,182
2,630
Stock-based compensation
67,027
73,367
61,602
104,629
95,994
Change in working capital
14,817
-67,384
5,671
-18,506
-39,729
Accounts payable
-5,784
-8,495
8,433
6,689
-11,511
Other working capital
-425,063
-541,138
-460,973
-378,554
663,935
Net cash provided by operating activities
-424,735
-540,585
-460,036
-378,182
664,280
Cash flows from investing activities
Investments in property, plant and equipment
-
-553
-937
-372
-345
Purchases of investments
-499,398
-594,670
-881,037
-1,990,151
-458,720
Sales/maturities of investments
887,208
1,038,136
1,207,407
988,075
901,749
Net cash used for investing activities
387,482
442,913
325,433
-1,002,448
442,684
Cash flows from financing activities
Common stock issued
-
-
0
0
417,500
Other financing activities
-2,503
-903
-43
-1,385
-
Net cash used provided by (used for) financing activities
4,912
6,027
3,070
13,334
426,762
Net change in cash
-32,341
-91,645
-131,533
-1,367,296
1,533,726
Cash at beginning of period
207,826
163,969
295,502
1,662,798
129,072
Cash at end of period
175,485
72,324
163,969
295,502
1,662,798
Free cash flow
Operating cash flow
-424,735
-540,585
-460,036
-378,182
664,280
Capital expenditure
-
-553
-937
-372
-345
Free cash flow
-425,063
-541,138
-460,973
-378,554
663,935